Riskpilot← Back to searchSign inGet full accessListeroptik AB
ABActiveOrg 5591920979Remelinvägen 4 ARetail sale of medical and orthopaedic goods · NACE 4774Est. 20193 employees
Revenue 2025
SEK 4,7M
+6% vs 2024
EBITDA margin
18.5%
+101% vs 2024
Equity ratio
42.0%
Financial strength
Net profit 2025
SEK 668K
+58% vs 2024
| Revenue | SEK 4,7M | +6% |
| EBITDA | SEK 874K | +101% |
| Net profit | SEK 668K | +58% |
| Total assets | SEK 1,9M | -8% |
| Equity | SEK 807K | -14% |
| Employees | 3 | — |
Legal name
Listeroptik AB
Org number
5591920979
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
22 januari 2019
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget bedriver detaljhandelsrörelse inom optik och därmed förenlig verksamhet i Sölvesborg kommun.
Address
Remelinvägen 4 A
Email
info.mjallby@hemkop.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 472 | 4 375 | 4 767 | 4 460 | 4 715 |
| Staff expenses | — | — | — | — | −1 666 |
| EBITDA | 925 | 531 | 663 | 434 | 874 |
| Depreciation & amort. | −89 | −97 | −113 | −113 | −101 |
| EBIT | 836 | 434 | 550 | 321 | 773 |
| Net financials | −1 | −1 | — | 40 | 0 |
| Profit before tax | 635 | 315 | 513 | 536 | 843 |
| Tax | −131 | −66 | −108 | −114 | 175 |
| Net profit | 504 | 249 | 405 | 422 | 668 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 284 | 2 599 | 1 835 | 2 089 | 1 919 |
| Equity | 1 063 | 1 312 | 517 | 939 | 807 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 686 | 633 | 627 | 634 | 665 |
| Total debt | 686 | 633 | 627 | 634 | 665 |
EBITDA margin
18.5%
This company
15.8%
Market median
+17% vs market
20212025
Equity ratio
42.0%
This company
38.2%
Market median
+10% vs market
20212025
Return on equity
82.8%
This company
18.4%
Market median
+350% vs market
20212025
Net profit margin
14.2%
This company
8.1%
Market median
+75% vs market
20212025
Asset turnover
2.46×
This company
1.12×
Market median
+120% vs market
20212025
Debt / equity
1.38×
This company
0.62×
Market median
-123% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CF | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Listeroptik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Filip Mounir Åkesson | Audit | 0 companies |
| Hanna Margareta Susanne Ingvarsson | Chairman | 0 companies |
| Per-Olof Lennart Asp | Deputy Board Member | 0 companies |
| Ove Jan Håkan Thomasson | Deputy Board Member | 0 companies |
| Per Inge Albin Håkansson | Board of Directors | 0 companies |